Press Releases Press Releases Year None202120202019201820172016 Date Title March 23, 2021 UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Business Updates SOUTH SAN FRANCISCO, Calif. , March 23, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the fourth quarter and full year ended December 31, 2020 March 11, 2021 UNITY Biotechnology Reports Granting of New Employment Inducement Award SOUTH SAN FRANCISCO, Calif. , March 11, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that Alexander Nguyen has officially joined UNITY as general counsel, and March 8, 2021 UNITY Biotechnology Announces Appointment of Alexander Nguyen as General Counsel SOUTH SAN FRANCISCO, Calif. , March 08, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that Alexander Nguyen has been appointed general counsel. February 26, 2021 UNITY Biotechnology to Participate in Upcoming March Investor Conferences SOUTH SAN FRANCISCO, Calif. , Feb. 26, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that members of its senior management team will participate in the following February 24, 2021 UNITY Biotechnology Reports Granting of New Employment Inducement Awards SOUTH SAN FRANCISCO, Calif. , Feb. 24, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that from February 9, 2021 through February 23, 2021 , the Board of February 8, 2021 Study published in Cell Metabolism Reveals New Therapeutic Approach Aimed at Restoring Vascular Health and Reversing Age-Related Eye Disease Study shows that senescent cells accumulate in the eye of patients with diabetic retinopathy, and elimination of these cells in preclinical models ameliorates disease Researchers at UNITY Biotechnology and University of Montreal provide mechanistic evidence supporting potential for vascular February 3, 2021 UNITY Biotechnology Reports Granting of New Employment Inducement Awards SOUTH SAN FRANCISCO, Calif. , Feb. 03, 2021 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced that from January 19, 2021 through February 2, 2021 , the Board of Directors February 1, 2021 UNITY Biotechnology Appoints Mike Sapieha, Ph.D., as Chief Scientific Advisor Mike Sapieha brings world-class expertise in aging-related ophthalmologic and neurologic diseases UNITY also names Jason Damiano , Ph.D., as vice president of translational biology and Nathan Guz , Ph.D., as vice president of operations SOUTH SAN FRANCISCO, Calif. , Feb.
